Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Cash from Financing Activities (2022 - 2026)

Envoy Medical's Cash from Financing Activities history spans 5 years, with the latest figure at $27.6 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 675.86% to $27.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $40.7 million, a 134.64% increase, with the full-year FY2025 number at $16.6 million, down 17.65% from a year prior.
  • Cash from Financing Activities hit $27.6 million in Q1 2026 for Envoy Medical, up from $6.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for COCH hit a ceiling of $27.6 million in Q1 2026 and a floor of -$1.5 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $5.5 million across 5 years, with a median of $4.0 million in 2023.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 172.7% in 2023 and later skyrocketed 675.86% in 2026.
  • Tracing COCH's Cash from Financing Activities over 5 years: stood at $2.0 million in 2022, then crashed by 172.7% to -$1.5 million in 2023, then skyrocketed by 486.31% to $5.6 million in 2024, then increased by 7.53% to $6.0 million in 2025, then surged by 356.52% to $27.6 million in 2026.
  • Business Quant data shows Cash from Financing Activities for COCH at $27.6 million in Q1 2026, $6.0 million in Q4 2025, and $2.6 million in Q3 2025.